We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current EQ market cap is 21.52M. The company's latest EPS is USD -0.3764 and P/E is -1.57.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.12M | 8.87M | 9.21M | 10.69M | 13.85M |
| Operating Income | -3.59M | -3.62M | -3.2M | -2.79M | -101k |
| Net Income | -3.34M | -3.71M | -2.34M | -2.73M | 468k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 15.76M | 36.08M |
| Operating Income | -26.73M | -29.55M | -37.79M | -62.08M | -14.52M |
| Net Income | -25.6M | -29.81M | -39.05M | -62.43M | -13.34M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 58.76M | 55.23M | 50.53M | 43.6M | 42.86M |
| Total Liabilities | 31.78M | 31.12M | 27.96M | 22.5M | 20.43M |
| Total Equity | 26.98M | 24.11M | 22.57M | 21.09M | 22.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 55.54M | 85.43M | 85.41M | 78.42M | 50.53M |
| Total Liabilities | 13.69M | 15.57M | 18.9M | 46.48M | 27.96M |
| Total Equity | 41.85M | 69.85M | 66.51M | 31.94M | 22.57M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.21M | -16.12M | -21.78M | -8.8M | -8.07M |
| Investing | -10.18M | 804k | -4.76M | -2.83M | -4.18M |
| Financing | -9.05M | -9.31M | -9.23M | N/A | 91k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.95M | -24.62M | -32.08M | -8.73M | -21.78M |
| Investing | -2.17M | -18.59M | 27.41M | 18.68M | -4.76M |
| Financing | 9.84M | 53.95M | 31.06M | -1.22M | -9.23M |
| Market Cap | 21.52M |
| Price to Earnings Ratio | -1.57 |
| Price to Sales Ratio | 0.58 |
| Price to Cash Ratio | 0.9 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 35.43M |
| Average Volume (1 week) | 157.24k |
| Average Volume (1 Month) | 114.31k |
| 52 Week Change | -15.46% |
| 52 Week High | 3.25 |
| 52 Week Low | 0.5605 |
| Spread (Intraday) | 0.02 (3.92%) |
| Company Name | Equillium Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.equilliumbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
